Agilent's Genome Technology to Accelerate Mesothelioma Fight

Agilent Technologies announced that its Human Genome CGH Microarray technology will be used by researchers at Melbourne, Australia's Peter MacCallum Cancer Centre in a three-year study designed to better understand mesothelioma, a cancer found in the lining of the chest, the abdominal cavity and around the heart, usually caused by exposure to asbestos.

TMCnet (http://www.tmcnet.com/usubmit/2005/Apr/1134444.htm)